Trial Profile
A phase 2a study of RV521 for the treatment of the RSV infection in adult stem cell transplant patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2018
Price :
$35
*
At a glance
- Drugs RV 521 (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 08 Aug 2018 New trial record